XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.1.9
NOTES PAYABLE (Details Narrative 1) (USD $)
12 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Oct. 31, 2012
Jun. 19, 2012
Number
Jun. 30, 2012
Oct. 30, 2011
Number
Jun. 30, 2011
Oct. 04, 2012
Oct. 31, 2011
Number
Sep. 30, 2012
Jul. 31, 2011
Debt Instrument [Line Items]                          
Repayments of notes payable   $ 4,691,847us-gaap_RepaymentsOfNotesPayable $ 1,850,000us-gaap_RepaymentsOfNotesPayable $ 200,000us-gaap_RepaymentsOfNotesPayable                  
Value of debt converted to shares     (6,716,504)us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature                    
Interest expense 1,165,981us-gaap_InterestExpense 1,905,409us-gaap_InterestExpense   64,380us-gaap_InterestExpense                  
Acrued interest paid   212,853us-gaap_InterestPaid 17,253us-gaap_InterestPaid 696us-gaap_InterestPaid                  
6% Notes issued in August and September 2012 [Member]                          
Debt Instrument [Line Items]                          
Aggregate principal amount                       1,600,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedInAugustAndSeptember2012Member
 
Repayments of notes payable         1,600,000us-gaap_RepaymentsOfNotesPayable
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedInAugustAndSeptember2012Member
               
6% Notes issued in September 2012 [Member]                          
Debt Instrument [Line Items]                          
Aggregate principal amount                       200,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedInSeptember2012Member
 
Repayments of notes payable         200,000us-gaap_RepaymentsOfNotesPayable
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedInSeptember2012Member
               
VitaMed July 2011 Secured Notes [Member]                          
Debt Instrument [Line Items]                          
Interest rate                         6.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotesMember
Aggregate principal and accrued interest           1,054,647us-gaap_LongTermDebt
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotesMember
             
Numbers of shares converted for debt           2,775,415us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotesMember
             
Conversion price (in dollars per share)           $ 0.38us-gaap_DebtInstrumentConvertibleConversionPrice1
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotesMember
             
Value of debt converted to shares           6,716,504us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotesMember
             
Interest expense     33,204us-gaap_InterestExpense
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotesMember
                   
VitaMed July 2011 First Secured Notes [Member]                          
Debt Instrument [Line Items]                          
Aggregate principal amount                         500,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotes1Member
VitaMed July 2011 Second Secured Notes [Member]                          
Debt Instrument [Line Items]                          
Aggregate principal amount                         500,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= txmd_July2011SecuredNotes2Member
VitaMed Promissory Notes [Member]                          
Debt Instrument [Line Items]                          
Repayments of notes payable               50,000us-gaap_RepaymentsOfNotesPayable
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
200,000us-gaap_RepaymentsOfNotesPayable
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
       
Interest rate                 4.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
       
Numbers of shares converted for debt               266,822us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
         
Conversion price (in dollars per share)               $ 0.38us-gaap_DebtInstrumentConvertibleConversionPrice1
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
         
Value of debt converted to shares               100,000us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
         
Interest expense   735us-gaap_InterestExpense
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
7,366us-gaap_InterestExpense
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
                   
Description of interest rate terms                 The VitaMed Notes were assumed by us upon the merger and bore interest at a rate of 4% per annum and were due at the earlier of (i) the six month anniversary of the date of issuance and (ii) such time as VitaMed received the proceeds of a promissory note(s) issued in an amount of not less than $1,000,000, or the Funding.        
Acrued interest paid             2,160us-gaap_InterestPaid
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
           
VitaMed Promissory Notes [Member] | Brian Bernick [Member]                          
Debt Instrument [Line Items]                          
Repayments of notes payable                   100,000us-gaap_RepaymentsOfNotesPayable
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_DirectorMember
     
Acrued interest paid                   5,341us-gaap_InterestPaid
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_DirectorMember
     
Aggregate remaining principal amount             100,000txmd_DebtInstrumentRemainingFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= txmd_VitaMedPromissoryNotesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_DirectorMember
           
VitaMed Convertible Notes [Member]                          
Debt Instrument [Line Items]                          
Aggregate principal amount                     534,160us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleNotesPayableMember
   
Interest rate                     4.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleNotesPayableMember
   
Numbers of shares converted for debt                     1,415,136us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleNotesPayableMember
   
Conversion price (in dollars per share)                     $ 0.38us-gaap_DebtInstrumentConvertibleConversionPrice1
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleNotesPayableMember
   
Notes Issued to Mr. Finizio And Mr. Milligan [Member]                          
Debt Instrument [Line Items]                          
Aggregate principal amount     100,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedToVariousPartiesMember
                   
Interest expense     6,344us-gaap_InterestExpense
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedToVariousPartiesMember
                   
Notes Issued to Mr. Finizio [Member]                          
Debt Instrument [Line Items]                          
Acrued interest paid             888us-gaap_InterestPaid
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedToParty1Member
           
Notes Issued to Mr. Milligan [Member]                          
Debt Instrument [Line Items]                          
Acrued interest paid                   $ 1,519us-gaap_InterestPaid
/ us-gaap_LongtermDebtTypeAxis
= txmd_NotesIssuedToParty2Member